The Doyle Group, Massachusetts Institute of Technology
Patrick S. Doyle is the Robert T. Haslam Professor in the Chemical Engineering Department at the Massachusetts Institute of Technology. A major theme of his research is the translation of molecular understanding of transport phenomena into new microfluidics-based processes. His lab studies a number of problems in soft matter with an emphasis on single molecule DNA dynamics, polymer physics, and microfluidic processes. He has developed new methods for the synthesis of complex microparticles and their applications by combining microfluidics and lithography in a process called Flow Lithography. Leveraging MIT Deshpande funding, in 2010 he co-founded the company Firefly Bioworks that commercialized barcoded particle technologies and was acquired by Abcam in 2015. In 2015 he co-founded Motif Micro which is commercializing his anti-counterfeiting technologies.
Among his awards are a NSF Career Award, 3M Innovation Award, Royal Society of Chemistry Pioneer in Miniaturization, Rothschild-Yvette Mayent Award, and Guggenheim Fellow. He has delivered several named Lectureships, including the Colburn Memorial Lecture, Thiele Lectureship, Van Ness Lectures, Stratis V. Sotirchos Memorial Lectureship and Royal Society of Chemistry Soft Matter Lectureship. He is an enthusiastic teacher and received the Michael Mohr Outstanding Faculty Award in 2013 & 2014 for his undergraduate fluid dynamics course.
Laboratory of Integrated Bio Medical Micro/Nanotechnology and Applications, University of Illinois
Rashid Bashir is Grainger Distinguished Chair and Head of Department of Bioengineering at UIUC. He is also serving as the Vice Dean of the new Carle-Illinois College of Medicine. Previously, he was the Able Bliss Professor of Engineering, Director of the Micro and Nanotechnology Laboratory (a campus-wide clean room facility), and Co-Director of the campus-wide Center for Nanoscale Science and Technology, a “collaboratory” aimed at facilitating center grants and large initiatives around campus in the area of nanotechnology. He has authored or co-authored over 210 journal papers, over 160 conference papers and conference abstracts, and over 120 invited talks, and has been granted 42 patents. He is a fellow of IEEE, AIMBE, AAAS, BMES, IAMBE, and APS.
His research interests include bionanotechnology, BioMEMS, lab on a chip, interfacing of biology and engineering from the molecular to the tissue scale, and applications of semiconductor fabrication to biomedical engineering, all applied to solving biomedical problems. He has been involved in 3 startups that have licensed his technologies.
In addition to leading his own research group, he was the PI on an NSF IGERT on Cellular and Molecular Mechanics and Bionanotechnology and PI on an NIH Training Grant on Cancer Nanotechnology. He is Co-Director and UIUC lead on an NSF Science and Technology Center on Emergent Behavior of Integrated Cellular Systems (with MIT, GT, and other partners). He also serves on the external advisory board of the NIH-funded BioMEMS Resource Center at Harvard/MGH and the NIH-funded Center for Cancer Nanotechnology Excellence at Stanford University, and on various editorial boards.
The Karp Lab, Harvard University
Dr. Jeff Karp is an Associate Professor at Brigham and Women’s Hospital, Harvard Medical School, Principal Faculty at the Harvard Stem Cell Institute, and an affiliate faculty at the Broad Institute and at the Harvard-MIT Division of Health Sciences and Technology (where he teaches to MIT-Sloan business school students). Several technologies developed in his lab have formed the foundation for multiple products on the market and currently under development and for the launch of four companies including Skintifique, Gecko Biomedical, Alivio Therapeutics, Frequency Therapeutics. Karp’s co-founded companies collectively employ >60 people.
The Boston Business Journal recognized him as a Champion in Healthcare Innovation and MIT’s Technology Review Magazine (TR35) also recognized Dr. Karp (3 members from his laboratory have subsequently received this award).
His work has been selected by Popular Mechanic’s “Top 20 New Biotech Breakthroughs that Will Change Medicine.” He gave a TEDMED talk on bioinspired medical innovation and since 2015 has been a member of the TEDMED Editorial Advisory Board. In 2015 and 2016 he received Breakthrough Awards from the Kenneth Rainin Foundation and in 2015 was a commencement speaker in at the University of Toronto.
Dr. Karp was selected as the Outstanding Faculty Undergraduate Mentor among all Faculty at MIT and he received the HST McMahon Mentoring award for being the top mentor of Harvard-MIT students. To date, 18 trainees from his laboratory have secured faculty positions and several have transitioned into impactful careers in pharma, biotech, medtech, and venture capital.
deMello Group, ETH Zurich
Andrew is Professor of Biochemical Engineering in the Department of Chemistry and Applied Biosciences at ETH Zurich. Prior to this he was Professor of Chemical Nanosciences and Head of the Nanostructured Materials and Devices Section at Imperial College London. He obtained a 1st Class Degree in Chemistry and PhD in Molecular Photophysics from Imperial College London in 1995 and subsequently held a Postdoctoral Fellowship in the Department of Chemistry at UC Berkeley. His research interests cover a broad range of activities in the areas of microfluidics and nanoscale science. Primary interests include the development of microfluidic devices for high-throughput biological analysis, ultra-sensitive optical detection techniques, novel methods for nanoparticle synthesis, the exploitation of semiconducting materials in diagnostic applications and the processing of living organisms.
Andrew has given over 300 invited lectures at conferences and universities in North America, Europe and Asia (including 70 plenary or keynote lectures), has published 280 papers in refereed journals, and co-authored two books. He currently sits on the Editorial Boards of Analytical Chemistry, Journal of Flow Chemistry, Advanced Materials Technology and CHEM. He is also co-founder of Molecular Vision Ltd, an Imperial College spin-out company developing low-cost diagnostic devices. Science originating from his group has been recognized through the award of the 2002 SAC Silver Medal (RSC), the 2009 Clifford Paterson Medal (The Royal Society), the 2009 Corday Morgan Medal (RSC), the 2007 Clark Memorial Lectureship (California State University) and the 2012 Pioneers of Miniaturization Lectureship by Dow Corning and the RSC.